An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels

著者: Eppie M. Yiu, Geneieve Tai, Roger E. Peverill, Katherine J. Lee, Kevin D. Croft, Trevor A. Mori, Barbara Scheiber‐Mojdehkar, Brigitte Sturm, Monika Praschberger, Adam P. Vogel, Gary Rance, Sarah Stephenson, Joseph P. Sarsero, Creina S. Stockley, Jetty Chung‐Yung Lee, Andrew Churchyard, Marguerite V. Evans‐Galea, Monique M. Ryan, Paul J. Lockhart, Louise A. Corben, Martin B. Delatycki - Journal of Neurology 2015 被引用: 112